Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:05.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:00.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:24:54.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T12:35:19.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A government funding lapse notice with NIH Clinical Center status and OPM updates appears at the top of the page, and the page revision is now v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T06:48:00.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Glossary toggle, the Last Update Submitted that Met QC Criteria label, No FEAR Act Data text, and a Revision: v3.4.0 tag were added, while the older Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. These changes are cosmetic and metadata-related and do not alter the study content.
    Difference
    0.1%
    Check dated 2026-01-28T04:48:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.